Akèy › Glakòm Ang Louvri
Etid klinik pou Glakòm Ang Louvri ap rekrite nan Etazini
34 etid pou Glakòm Ang Louvri ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Philadelphia, PA5 etid
- Kenosha, WI5 etid
- Austin, TX3 etid
- Dallas, TX3 etid
- El Paso, TX3 etid
- Boston, MA3 etid
- Oklahoma City, OK3 etid
- Houston, TX3 etid
- Roswell, GA3 etid
- Santa Rosa, CA3 etid
Pa eta
- Arizona4 etid
- Colorado4 etid
- Florid6 etid
- Georgia3 etid
- Kalifòni9 etid
- Maryland3 etid
- Massachusetts4 etid
- Minnesota3 etid
- Ohio3 etid
- Oklahoma3 etid
- Pennsylvania6 etid
- Texas9 etid
- Wisconsin5 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
iDose TR Administration in an Office-Based Surgery Setting
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07816692Adaptive Optics OCT Evaluation of Rhopressa's Effects on the Retinal Ganglion Cells in Glaucoma Patients
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07847073REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07675824A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Ap rekriteFaz 3
Laj 45 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06822738A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07661329Hydrus® Microstent New Enrollment Post-Approval Study
Ap rekrite
Laj 45 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT04553523Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07075718A Study to Assess Brillouin Hydration Mapping for the Evaluation of Ocular Tissues and Diseases
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 20 a 79 · Tout sèks · Mizajou Aug 25, 2026 · NCT07780890Caffeine Consumption in Glaucoma Patients and Healthy Subjects
Ap rekriteVolontè an sante akeyi
Laj 18 a 90 · Tout sèks · Mizajou Aug 20, 2026 · NCT03675412Travoprost Intraocular Implant + iStent Infinite
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Jun 2, 2026 · NCT06066645Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)
Ap rekriteFaz 1
Laj 40 a 85 · Tout sèks · Mizajou May 19, 2026 · NCT07290244Adaptive Optics Retinal Imaging
Ap rekriteVolontè an sante akeyi
Laj 21 ak plis · Tout sèks · Mizajou May 8, 2026 · NCT05370287Direct vs Standard SLT for Glaucoma: A Noninferiority Trial
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT0740815424-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou May 1, 2026 · NCT07325240DSLT for Reducing Medication in Glaucoma
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Apr 20, 2026 · NCT07390890Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Mar 30, 2026 · NCT07495852A Trial of Hydrus Microstent Versus Goniotomy
Ap rekrite
Laj 40 a 85 · Tout sèks · Mizajou Mar 30, 2026 · NCT06289491Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Mar 5, 2026 · NCT07217678Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Feb 27, 2026 · NCT07400926Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
Ap rekriteFaz 4
Laj 45 ak plis · Tout sèks · Mizajou Jan 21, 2026 · NCT06848946Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
Ap rekrite
Laj 45 ak plis · Tout sèks · Mizajou Dec 15, 2025 · NCT07220876Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Nov 14, 2025 · NCT07228221Electrical Stimulation for Vision Neuroenhancement in Glaucoma
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Nov 4, 2025 · NCT06685211Diagnostic Innovations in Glaucoma Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Oct 24, 2025 · NCT00221897Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Sep 12, 2025 · NCT04396002Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.